北極星藥業集團股份有限公司
北極星藥業集團股份有限公司（Polaris Group）為一家國際性的新藥研發公司，專注於抗癌藥物的開發。核心產品為生物藥「ADI-PEG 20」，這是一種針對精胺酸代謝缺陷之癌症（如肺間皮癌、肝癌、膠質母細胞瘤等）的標靶代謝療法，目前在多項適應症中進入臨床三期或取得顯著進展。公司亦提供委託開發暨製造服務（CDMO），具備先進的生物藥製造設施。公司成立於 2006 年，總部位於台灣台北市。
該股 RSI(6) 為 26.9，處於偏低區間，短線賣壓漸緩。股價跌破5日、20日、60日、120日均線。短中期均線呈空頭排列，趨勢偏空。KD 指標偏低（K=5.8），有反彈空間；MACD 柱狀體為負值，空方動能持續。 （自動產生 · 非投資建議）
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 09-16 | +59 | 0 | 0 | +59 |
| 09-15 | +86 | 0 | 0 | +86 |
| 09-14 | -833 | 0 | 0 | -833 |
| 09-11 | -1,264 | 0 | -22 | -1,286 |
| 09-10 | -292 | 0 | +15 | -277 |
| 09-09 | -512 | 0 | -2 | -514 |
| 09-08 | -753 | 0 | +2 | -751 |
| 09-07 | -264 | 0 | 0 | -264 |
| 09-04 | -50 | 0 | 0 | -50 |
| 09-03 | -283 | 0 | 0 | -283 |
| 09-02 | +82 | 0 | -4 | +78 |
| 09-01 | +103 | 0 | +4 | +107 |
| 08-31 | -139 | 0 | +3 | -136 |
| 08-28 | +74 | 0 | +5 | +79 |
| 08-27 | -599 | 0 | -1 | -600 |
| 08-26 | -164 | 0 | +12 | -152 |
| 08-25 | -130 | 0 | -2 | -132 |
| 08-24 | -2,719 | 0 | +4 | -2,715 |
| 08-21 | -97 | 0 | 0 | -97 |
| 08-20 | +463 | 0 | -7 | +457 |
| 08-19 | +260 | 0 | +4 | +264 |
| 08-18 | -367 | 0 | +1 | -366 |
| 08-17 | -217 | 0 | +5 | -212 |
| 08-14 | -260 | 0 | 0 | -260 |
| 08-13 | +166 | 0 | +2 | +168 |
| 08-12 | -158 | 0 | 0 | -158 |
| 08-11 | -197 | 0 | -4 | -201 |
| 08-10 | +223 | 0 | +1 | +224 |
| 08-07 | +24 | 0 | 0 | +24 |
| 08-06 | -19 | 0 | -2 | -21 |
| 08-05 | +514 | 0 | 0 | +514 |
| 08-04 | -67 | 0 | -18 | -85 |
| 08-03 | +656 | 0 | -20 | +636 |
| 07-31 | -800 | 0 | +7 | -793 |
| 07-30 | +74 | 0 | -4 | +70 |
| 07-29 | +268 | 0 | -1 | +267 |
| 07-28 | +107 | 0 | +1 | +108 |
| 07-27 | +469 | 0 | +2 | +471 |
| 07-24 | -25 | 0 | -2 | -27 |
| 07-23 | -283 | 0 | +6 | -277 |
| 07-22 | -683 | 0 | +4 | -679 |
| 07-21 | +154 | 0 | -1 | +153 |
| 07-20 | +577 | 0 | +13 | +590 |
| 07-17 | -185 | 0 | +1 | -184 |
| 07-16 | +330 | 0 | -9 | +321 |
| 07-15 | +166 | 0 | -7 | +159 |
| 07-14 | -43 | 0 | +22 | -21 |
| 07-13 | -1,006 | 0 | +9 | -997 |
| 07-09 | -246 | 0 | -6 | -252 |
| 07-08 | -155 | 0 | -7 | -162 |
| 07-07 | +97 | 0 | +2 | +99 |
| 07-06 | -64 | 0 | -1 | -65 |
| 07-03 | +671 | 0 | +8 | +679 |
| 07-02 | -282 | 0 | -1 | -283 |
| 07-01 | -158 | 0 | +2 | -156 |
| 06-30 | +372 | 0 | -7 | +365 |
| 06-29 | +922 | 0 | 0 | +922 |
| 06-26 | -772 | 0 | -1 | -773 |
| 06-25 | -665 | 0 | 0 | -665 |
| 06-24 | +461 | 0 | +2 | +463 |
| 06-22 | -671 | 0 | -4 | -675 |
| 06-18 | +141 | 0 | -2 | +139 |
| 06-17 | -167 | 0 | +2 | -165 |
| 06-16 | +244 | 0 | +1 | +245 |
| 06-15 | +145 | 0 | +6 | +151 |
| 06-12 | -265 | 0 | -1 | -266 |
| 06-10 | +91 | 0 | -6 | +85 |
| 06-09 | -217 | 0 | -4 | -221 |
| 06-08 | +247 | 0 | -11 | +236 |
| 06-04 | -189 | 0 | -4 | -193 |
| 06-03 | +285 | 0 | -1 | +284 |
| 06-02 | +121 | 0 | -6 | +115 |
| 06-01 | +459 | 0 | 0 | +459 |
| 05-29 | -661 | 0 | +7 | -654 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/08 | 450 萬 | - | +202.6% |
| 2026/07 | -3,571,000 | -193.8% | -211.7% |
| 2026/06 | 381 萬 | +137.8% | -19.0% |
| 2026/05 | 160 萬 | -4.0% | +248.7% |
| 2026/04 | 167 萬 | +5.7% | -57.1% |
| 2026/03 | 158 萬 | -90.7% | -59.7% |
| 2026/02 | 1694 萬 | -8.1% | +322.9% |
| 2026/01 | 1843 萬 | +492.9% | +1275.3% |
| 2025/12 | 311 萬 | +11.5% | -40.7% |
| 2025/11 | 279 萬 | +1359.7% | -81.3% |
| 2025/10 | 19 萬 | -98.5% | -98.8% |
| 2025/09 | 1318 萬 | - | +310.1% |